CORRADO ADVISORS, LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 85 filers reported holding ENZO BIOCHEM INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
CORRADO ADVISORS, LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q4 2022$786
-98.9%
550
-97.2%
0.00%
-97.7%
Q3 2021$69,000
-5.5%
19,366
-15.6%
0.04%
-4.4%
Q2 2021$73,000
-54.7%
22,956
-51.0%
0.04%
-62.2%
Q1 2021$161,000
-6.9%
46,816
-31.8%
0.12%
-10.5%
Q4 2020$173,000
-17.6%
68,666
-31.2%
0.13%
-23.6%
Q3 2020$210,000
-11.0%
99,791
-5.3%
0.17%
-18.7%
Q2 2020$236,000
-48.7%
105,414
-42.1%
0.21%
-50.2%
Q1 2020$460,000
-6.7%
182,015
-2.8%
0.43%
-1.8%
Q4 2019$493,000
-30.3%
187,310
-4.6%
0.44%
-31.2%
Q3 2019$707,000
+5.7%
196,309
-1.1%
0.64%
+6.3%
Q2 2019$669,000
+12.4%
198,544
-8.8%
0.60%
+9.9%
Q1 2019$595,000
-4.3%
217,803
-2.7%
0.54%
-11.2%
Q4 2018$622,000
-54.3%
223,783
-32.2%
0.61%
-30.7%
Q3 2018$1,360,000
-24.2%
330,093
-4.5%
0.89%
-18.5%
Q2 2018$1,794,000
+6.0%
345,795
+12.0%
1.09%
+7.1%
Q1 2018$1,693,000
-15.0%
308,878
+26.4%
1.02%
-12.8%
Q4 2017$1,991,000
-20.3%
244,294
+2.3%
1.16%
-17.2%
Q3 2017$2,499,000
-30.6%
238,726
-26.8%
1.41%
-28.7%
Q2 2017$3,600,000
+37.0%
326,101
+3.9%
1.97%
+30.7%
Q1 2017$2,627,000
+2755.4%
313,911
+2275.4%
1.51%
+2549.1%
Q4 2016$92,000
+39.4%
13,215
+2.3%
0.06%
+35.7%
Q3 2016$66,000
+34.7%
12,915
+20.7%
0.04%
+35.5%
Q1 2016$49,00010,7000.03%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders